Researcher
Ann Belmans
- Disciplines:Applied mathematics in specific fields, Statistics and numerical methods, Scientific computing, Bioinformatics and computational biology, Public health care, Public health services
Affiliations
- Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat) (Division)
Member
From1 Oct 2001 → 8 Apr 2017
Publications
1 - 10 of 84
- 10-year follow-up results of the European Achalasia Trial: a multicentre randomised controlled trial comparing pneumatic dilation with laparoscopic Heller myotomy(2024)
Authors: Guy Boeckxstaens, Ann Belmans, Jan Tack, Tim Vanuytsel
- Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trial(2024)
Authors: Lisse Decraecker, Joris Arts, Willy Peetermans, Tim Vanuytsel, Ann Belmans, Guy Boeckxstaens
Pages: 459 - 469 - Lifelong endurance exercise and its relation with coronary atherosclerosis(2023)
Authors: Christophe Dausin, Piet Claus, Jan Bogaert, Kaatje Goetschalckx, Andre La Gerche, Rik Willems, Guido Claessen, Peter Hespel, Tom Dresselaers, Ann Belmans
Pages: 2388 - 2399 - Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study(2023)
Authors: Ann Belmans, Kris Bogaerts, Regina Esi Mensimah Baiden-Amissah, Diether Lambrechts, Frédéric Amant
Pages: 475 - 491 - Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study(2022)
Authors: Quentin Van Thillo, Iwein Gyselinck, Caroline Martens, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, et al.
- Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma(2022)
Authors: Timothy Devos, Quentin Van Thillo, Iwein Gyselinck, Piet Maes, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Geert Meyfroidt
- Ninety-Day Follow-up Is Inadequate for Diagnosis of Fracture-related Infections in Patients with Open Fractures(2022)
Authors: Peter Declercq, Ann Belmans, Willem-Jan Metsemakers
Pages: 139 - 146 - Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)(2022)
Authors: Iwein Gyselinck, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Wim Janssens, Robin Vos
- itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens (vol 66, 103288, 2021)(2021)
Authors: Laurens Liesenborghs, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Sebastiaan ter Horst, Erwin Dreesen, Tatjana Geukens, Ewout Landeloos, Bert Vandenberk, Lorenz Van der Linden, et al.
- Tranexamic acid and bleeding in patients treated with non-vitamin K oral anticoagulants undergoing dental extraction: The EXTRACT-NOAC randomized clinical trial(2021)
Authors: Anna Ockerman, Thomas Vanassche, Ann Belmans, Joeri Meyns, Reinhilde Jacobs, Constantinus Politis, Peter Verhamme